Promising trial for Alzheimer's treatment

Eli Lilly last week announced the results of a Phase 3 trial on its experimental drug called Donanemab. The latest drug trial in a new class of Alzheimer’s drugs gives researchers and advocates renewed hope of slowing the progression of the brain disease.

FDA approves RSV vaccine

The U.S. approved the first vaccine for RSV on Wednesday, shots to protect older adults against a respiratory virus that’s most notorious for attacking babies but endangers their grandparents, too.